Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (940)
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
9,683
Price
$2.75
Total Value
$26.66K
Shares Held After
258,688
% of Holdings
3.6%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
34,463
Price
$2.67
Total Value
$91.90K
Shares Held After
1,226,427
% of Holdings
2.7%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
10,257
Price
$2.74
Total Value
$28.11K
Shares Held After
318,480
% of Holdings
3.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
625
Price
$206.15
Total Value
$128.85K
Shares Held After
17,090
% of Holdings
3.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
2,128
Price
$205.19
Total Value
$436.64K
Shares Held After
17,715
% of Holdings
10.7%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
7,271
Price
$204.35
Total Value
$1.49M
Shares Held After
19,843
% of Holdings
26.8%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
26,160
Price
$203.55
Total Value
$5.32M
Shares Held After
27,114
% of Holdings
49.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
12,919
Price
$202.48
Total Value
$2.62M
Shares Held After
53,274
% of Holdings
19.5%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
6,597
Price
$201.47
Total Value
$1.33M
Shares Held After
66,193
% of Holdings
9.1%
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
300
Price
$200.56
Total Value
$60.17K
Shares Held After
72,790
% of Holdings
0.4%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
1,099
Price
$10.24
Total Value
$11.25K
Shares Held After
366,529
% of Holdings
0.3%
NovaBridge Biosciences (NBP)
Xu Cong Claire — EVP, Clinical Development
Shares
3,282
Price
$0.79
Total Value
$2.59K
Shares Held After
304,201
% of Holdings
1.1%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,525
Price
$1.56
Total Value
$3.95K
Shares Held After
2,896
% of Holdings
46.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
28,188
Price
$106.20
Total Value
$2.99M
Shares Held After
114,024
% of Holdings
19.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
11,514
Price
$105.37
Total Value
$1.21M
Shares Held After
142,212
% of Holdings
7.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
23,072
Price
$104.59
Total Value
$2.41M
Shares Held After
153,726
% of Holdings
13.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Sayad Pierre Sargis — Chief Medical Officer
Shares
12,000
Price
$12.18
Total Value
$146.16K
Shares Held After
9,519
% of Holdings
55.8%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.24
Total Value
$526.80K
Shares Held After
377,820
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
10,000
Price
$70.24
Total Value
$702.40K
Shares Held After
58,555
% of Holdings
14.6%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
33,818
Price
$36.44
Total Value
$1.23M
Shares Held After
1,599,154
% of Holdings
2.1%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
166,182
Price
$35.63
Total Value
$5.92M
Shares Held After
1,632,972
% of Holdings
9.2%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,000
Price
$2.80
Total Value
$2.80K
Shares Held After
33,000
% of Holdings
2.9%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
700
Price
$60.98
Total Value
$42.68K
Shares Held After
2
% of Holdings
99.7%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
6,368
Price
$60.17
Total Value
$383.15K
Shares Held After
702
% of Holdings
90.1%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$27.58
Total Value
$206.82K
Shares Held After
26,250
% of Holdings
22.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$524.42
Total Value
$104.88K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
6
Price
$523.42
Total Value
$3.14K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$522.40
Total Value
$270.08K
Shares Held After
324,649
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$521.58
Total Value
$149.17K
Shares Held After
325,166
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
751
Price
$520.30
Total Value
$390.74K
Shares Held After
325,452
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$519.19
Total Value
$213.91K
Shares Held After
326,203
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$518.14
Total Value
$697.42K
Shares Held After
326,615
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$517.11
Total Value
$768.42K
Shares Held After
327,961
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,386
Price
$516.16
Total Value
$1.23M
Shares Held After
329,447
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$515.46
Total Value
$840.20K
Shares Held After
331,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$514.26
Total Value
$246.84K
Shares Held After
333,463
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$43.27
Total Value
$64.91K
Shares Held After
116,731
% of Holdings
1.3%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
128
Price
$61.77
Total Value
$7.91K
Shares Held After
59,745
% of Holdings
0.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
13,485
Price
$60.21
Total Value
$811.93K
Shares Held After
59,873
% of Holdings
18.4%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
36,387
Price
$58.64
Total Value
$2.13M
Shares Held After
73,358
% of Holdings
33.2%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,304
Price
$2.85
Total Value
$3.72K
Shares Held After
34,000
% of Holdings
3.7%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
8,222
Price
$12.01
Total Value
$98.74K
Shares Held After
142,047
% of Holdings
5.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
300
Price
$252.76
Total Value
$75.83K
Shares Held After
65,686
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
9,259
Price
$251.95
Total Value
$2.33M
Shares Held After
65,986
% of Holdings
12.3%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
19,639
Price
$250.60
Total Value
$4.92M
Shares Held After
75,245
% of Holdings
20.7%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,113
Price
$250.02
Total Value
$4.53M
Shares Held After
94,884
% of Holdings
16.0%
Showing 1–50 of 940 transactions (page 1 of 19)